History in the name of 90-year-old Maggie
When 90-year-old Keenan returned with the vaccine, the hospital staff greeted him with applause. She became the first person in the country to get a vaccine. Maggie, who was wearing a blue ‘Merry Christmas’ t-shirt, smiled under the mask. She told people that if she can take the vaccine at the age of 90, anyone can. He is said to be lucky to get the vaccine first.
Second dose after 21 days
The vaccine dose will be injected into the upper arm. A second shot will be given 21 days later. A little immunity will be available 12 days after the first dose and fully 7 days after the second dose. People in Britain are taking ‘Call’ and ‘Recall’ appointments for the vaccine. They will reach the first dose through Call and then the second dose from Recall.
William Shakespeare also got vaccinated
The second person to receive the vaccine was William Shakespeare. When people came to know this on social media, they started remembering the playwright William Shakespeare, one of the greatest and famous personalities in the history of literature. Even his dialogue ‘To be or not to be’ written in ‘Hamlet’, people started writing ‘To V or not to V’ for the vaccine.
Also effective on the elderly
As of now, it has been found in the analysis that 95% of the people with the vaccine have been saved from Kovid-19. At the same time, it has affected 94% of the people in the elderly. The immunity from this can last for at least 6 months or more. In Britain, the vaccine is being given to the elderly for the first time and so far those taking it have appealed to trust the health system.
Is there any danger with the vaccine?
No serious side-effects have been found in the trial of the vaccine. Some people saw arms pain, fever or muscle aches but this was not much worrisome. The Medicines and Healthcare Products Regulatory Agency in the UK is monitoring any serious effects. At the same time, people have to stop for 15 minutes after giving the vaccine so that a reaction can be registered.
What is the challenge?
None of the vaccines yet to be made have been made from mRNA. This vaccine prepares the human body to produce proteins that produce protective antibodies. Because of this, deep-freeze production, storage and transportation networks are needed so that the vaccine can last for a long time.
Who is being given first
In the first phase, elderly and workers in care homes in the UK, people 80 years or older, frontline health and social care workers, 75 years or more, 65 years or older, people aged 16–64 Vaccines will be given to those who are at greater risk of infection, 60 years or more, people aged 55 years or more, and finally 50 years or more by January.
Will India also get?
Pfizer has also sought permission for use in India, but Rajesh Bhushan, secretary of the Union Ministry of Health, says that India is currently not in a position to increase existing cold-chain capacity. Not only this, it will also be a challenge to deliver the vaccine in a short time apart from temperature. To give this, paramedical staff will also have to be trained. It would be difficult to deliver the vaccine in places where the vaccination centers are away or where people are not ready for vaccination.